Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
qdWvzNRfqc5dtrcG